Boston Scientific (BSX) Q3 2024 Earnings
Boston Scientific reported Q3 2024 revenue of $4.2B, beat analyst consensus of $4.0B by $168.2M. Diluted EPS came in at $0.63, beat the $0.59 consensus by $0.04. Boston Scientific reports across 2 business segments, led by Cardiovascular and MedSurg.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Boston Scientific's Q3 2024 earnings report.
Boston Scientific (BSX) reported Q3 2024 earnings on October 23, 2024 before market open.
Boston Scientific reported revenue of $4.2B and diluted EPS of $0.63 for Q3 2024.
Revenue beat the consensus estimate of $4.0B by $168.2M. EPS beat the consensus estimate of $0.59 by $0.04.
You can read the 10-Q periodic report (0000885725-24-000073) directly on SEC EDGAR. The filing index links above go to sec.gov.